Amedeo Smart

Free Medical Literature Service


 

Amedeo

Colorectal Neoplasms

  Free Subscription

Articles published in
J Clin Oncol
    August 2017
  1. DOTAN E, Cohen SJ, Starodub AN, Lieu CH, et al
    Phase I/II Trial of Labetuzumab Govitecan (Anti-CEACAM5/SN-38 Antibody-Drug Conjugate) in Patients With Refractory or Relapsing Metastatic Colorectal Cancer.
    J Clin Oncol. 2017 Aug 17:JCO2017739011. doi: 10.1200/JCO.2017.73.9011.
    >> Share

  2. IKOMA N, You YN, Bednarski BK, Rodriguez-Bigas MA, et al
    Impact of Recurrence and Salvage Surgery on Survival After Multidisciplinary Treatment of Rectal Cancer.
    J Clin Oncol. 2017;35:2631-2638.
    >> Share

  3. EBISCH RMF, Rutten DWE, IntHout J, Melchers WJG, et al
    Long-Lasting Increased Risk of Human Papillomavirus-Related Carcinomas and Premalignancies After Cervical Intraepithelial Neoplasia Grade 3: A Population-Based Cohort Study.
    J Clin Oncol. 2017;35:2542-2550.
    >> Share

  4. ESPENSCHIED CR, LaDuca H, Li S, McFarland R, et al
    Multigene Panel Testing Provides a New Perspective on Lynch Syndrome.
    J Clin Oncol. 2017;35:2568-2575.
    >> Share

    July 2017
  5. KASTRINOS F, Uno H, Ukaegbu C, Alvero C, et al
    Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome.
    J Clin Oncol. 2017;35:2165-2172.
    >> Share

    June 2017
  6. BURRIS HA, Infante JR, Ansell SM, Nemunaitis JJ, et al
    Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors.
    J Clin Oncol. 2017;35:2028-2036.
    >> Share

  7. HUA X, Phipps AI, Burnett-Hartman AN, Adams SV, et al
    Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival.
    J Clin Oncol. 2017 Jun 15:JCO2017723569. doi: 10.1200/JCO.2017.72.3569.
    >> Share

    May 2017
  8. DANIELS MS, Bannon SA, Mork ME
    Frequency of Germline BRCA1/2 Mutations in Unselected Patients With Colorectal Cancer.
    J Clin Oncol. 2017 May 16:JCO2017727222. doi: 10.1200/JCO.2017.72.7222.
    >> Share

  9. JONES JC, Renfro LA, Al-Shamsi HO, Schrock AB, et al
    Non-V600 BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer.
    J Clin Oncol. 2017 May 9:JCO2016714394. doi: 10.1200/JCO.2016.71.4394.
    >> Share

  10. VAN DE WAL M, Thewes B, Gielissen M, Speckens A, et al
    Efficacy of Blended Cognitive Behavior Therapy for High Fear of Recurrence in Breast, Prostate, and Colorectal Cancer Survivors: The SWORD Study, a Randomized Controlled Trial.
    J Clin Oncol. 2017 May 4:JCO2016705301. doi: 10.1200/JCO.2016.70.5301.
    >> Share

    April 2017
  11. GROOT KOERKAMP B, Sadot E, Kemeny NE, Gonen M, et al
    Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis.
    J Clin Oncol. 2017 Apr 20:JCO2016718346. doi: 10.1200/JCO.2016.71.8346.
    >> Share

  12. RENFRO LA, Goldberg RM, Grothey A, Sobrero A, et al
    Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancerologie Digestive Database.
    J Clin Oncol. 2017 Apr 17:JCO2016715771. doi: 10.1200/JCO.2016.71.5771.
    >> Share

  13. HAMADA T, Cao Y, Qian ZR, Masugi Y, et al
    Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.
    J Clin Oncol. 2017 Apr 13:JCO2016707547. doi: 10.1200/JCO.2016.70.7547.
    >> Share

    March 2017
  14. SUD A, Thomsen H, Sundquist K, Houlston RS, et al
    Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History.
    J Clin Oncol. 2017 Mar 13:JCO2016709709. doi: 10.1200/JCO.2016.70.9709.
    >> Share

  15. GARG MK, Zhao F, Sparano JA, Palefsky J, et al
    Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205).
    J Clin Oncol. 2017;35:718-726.
    >> Share

    February 2017
  16. SEPULVEDA AR, Hamilton SR, Allegra CJ, Grody W, et al
    Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology.
    J Clin Oncol. 2017 Feb 6:JCO2016719807. doi: 10.1200/JCO.2016.71.9807.
    >> Share

    January 2017
  17. YURGELUN MB, Kulke MH, Fuchs CS, Allen BA, et al
    Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
    J Clin Oncol. 2017 Jan 30:JCO2016710012. doi: 10.1200/JCO.2016.71.0012.
    >> Share

  18. CASADABAN L, Maker AV
    Can Colon Cancer Recurrence and Metastases Be Determined After Surgical Resection Using a Gene Expression Signature?
    J Clin Oncol. 2017 Jan 23:JCO2016711572. doi: 10.1200/JCO.2016.71.1572.
    >> Share

    December 2016
  19. NAGTEGAAL ID, Knijn N, Hugen N, Marshall HC, et al
    Tumor Deposits in Colorectal Cancer: Improving the Value of Modern Staging-A Systematic Review and Meta-Analysis.
    J Clin Oncol. 2016 Dec 28:JCO2016689091.
    >> Share

  20. SPARANO JA, Lee JY, Palefsky J, Henry DH, et al
    Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium Trial.
    J Clin Oncol. 2016 Dec 12:JCO2016691642.
    >> Share

  21. LOEHRER AP, Song Z, Haynes AB, Chang DC, et al
    Impact of Health Insurance Expansion on the Treatment of Colorectal Cancer.
    J Clin Oncol. 2016;34:4110-4115.
    >> Share

    September 2016
  22. CESPEDES FELICIANO EM, Kroenke CH, Meyerhardt JA, Prado CM, et al
    Metabolic Dysfunction, Obesity, and Survival Among Patients With Early-Stage Colorectal Cancer.
    J Clin Oncol. 2016 Sep 6. pii: JCO674473.
    >> Share

    August 2016
  23. SARGENT DJ, Andre T, Grothey A
    Further Evaluating the Benefit of Adjuvant Chemotherapy for Colon Cancer.
    J Clin Oncol. 2016 Aug 15. pii: JCO684886.
    >> Share

  24. DALY LE, Ryan AM, Power DG
    Response to "Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer".
    J Clin Oncol. 2016 Aug 1. pii: JCO688010.
    >> Share

    July 2016
  25. NIEDZWIECKI D, Frankel WL, Venook AP, Ye X, et al
    Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance).
    J Clin Oncol. 2016 Jul 18. pii: JCO654699.
    >> Share

    June 2016
  26. YAMANAKA T, Oki E, Yamazaki K, Yamaguchi K, et al
    12-Gene Recurrence Score Assay Stratifies the Recurrence Risk in Stage II/III Colon Cancer With Surgery Alone: The SUNRISE Study.
    J Clin Oncol. 2016 Jun 20. pii: JCO670414.
    >> Share

    May 2016
  27. BAINS SJ, Mahic M, Myklebust TA, Smastuen MC, et al
    Aspirin As Secondary Prevention in Patients With Colorectal Cancer: An Unselected Population-Based Study.
    J Clin Oncol. 2016 May 31. pii: JCO653519.
    >> Share

    April 2016
  28. RICCI R, Martini M, Cenci T, Antinori A, et al
    Case of Rectal GI Stromal Tumor Demonstrating that KIT and PDGFRA Mutations Are Not Always Mutually Exclusive.
    J Clin Oncol. 2016;34:e107-9.
    >> Share

  29. HOCHSTER HS, Niedzwiecki D
    Big Data, Small Effects.
    J Clin Oncol. 2016;34:1170-1.
    >> Share

  30. GASPAROTTO D, Rossi S, Campagna D, Scavina P, et al
    Imatinib-Sensitizing KIT Mutation in a Carney-Stratakis-Associated GI Stromal Tumor.
    J Clin Oncol. 2016;34:e99-e103.
    >> Share

    March 2016
  31. VENTURINI F, Gambi V, Di Lernia S, Vanzulli A, et al
    Linitis Plastica of the Rectum As a Clinical Presentation of Metastatic Lobular Carcinoma of the Breast.
    J Clin Oncol. 2016;34:e54-6.
    >> Share

    January 2016
  32. DEENEN MJ, Meulendijks D, Cats A, Sechterberger MK, et al
    Upfront Genotyping of DPYD*2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis.
    J Clin Oncol. 2016;34:227-34.
    >> Share

  33. HEGARTY S, Shapiro PJ, Fang CY, Barsevick AM, et al
    Physical and mental functioning in colorectal cancer (CRC) survivors by work status.
    J Clin Oncol. 2016;34.
    >> Share

  34. SMITH V, Danus S, Schnell M, Lindquist J, et al
    Colorectal cancer survivorship statistics: A Veterans Affairs Central Cancer Registry analysis.
    J Clin Oncol. 2016;34.
    >> Share

  35. VAN LOON K, You YN, Hu CY, Francescatti AB, et al
    How clinicians make decisions regarding surveillance and treatment of colorectal cancer (CRC) patients.
    J Clin Oncol. 2016;34.
    >> Share

  36. GOUGH K, Drosdowsky A, Russell L, Aranda S, et al
    A randomized controlled trial (RCT) of a supportive care package (SurvivorCare, SC) for survivors of colorectal cancer (CRC).
    J Clin Oncol. 2016;34.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016